Eugenio Villa

Gemcitabine versus cisplatin, epirubicin, fluorouracil, and gemcitabine in advanced pancreatic cancer: a randomised controlled multicentre phase III trial

Michele Reni, Stefano Cordio, Carlo Milandri et al. · The Lancet Oncology · 2005 · 274 citations

Medicine, Oncology, Pharmacology +9

Pharmacogenetics of ABCG2 and Adverse Reactions to Gefitinib

George Cusatis, Vanesa Gregorc, Jing Li et al. · JNCI Journal of the National Cancer Institute · 2006 · 241 citations · Full text

Medicine, Oncology, Pharmacology +17

Gefitinib in Pretreated Non–Small-Cell Lung Cancer (NSCLC): Analysis of Efficacy and Correlation With HER2 and Epidermal Growth Factor Receptor Expression in Locally Advanced or Metastatic NSCLC

Federico Cappuzzo, Vanesa Gregorc, Elisa Rossi et al. · Journal of Clinical Oncology · 2003 · 214 citations

Medicine, Oncology, Pharmacology +17

Lethal pulmonary complications significantly correlate with individually assessed mean lung dose in patients with hematologic malignancies treated with total body irradiation

Aldo Della Volpe, Andrés J.M. Ferreri, C. Annaloro et al. · International Journal of Radiation Oncology*Biology*Physics · 2002 · 111 citations

Medicine, Oncology, Radiation Oncology +17

Importance of complete staging in non-Hodgkin's lymphoma presenting as a cerebral mass lesion

Andrés J.M. Ferreri, Michele Reni, Maria Cristina Zoldan et al. · Cancer · 1996 · 87 citations · Full text

Medicine, Hematology, Oncology +10